Alira Health’s Transformation Talks: Real-World Data to Support HTAs in Europe

Published on:
April 28, 2022

In this new episode titled “Real-World Data to Support HTAs in Europe”, we will examine the various uses of Real-World Data (RWD) and how it is valued in Health Technology Assessments in multiple European nations. Learn more about using RWD as support in HTAs and its direct impact on HTAs budgets, results, and even patient outcomes by listening to this episode of Transformation Talks.

Meet our guests:

Catia Proenca – Director, Clinical Real-World Evidence, Alira Health 

Catia designs and manages Real-World Evidence strategies maintaining a Market Access perspective by ensuring key stakeholder needs (e.g., HTA, payers) are met, thus, maximizing access to innovation, and ultimately improving patient outcomes. With 13+ years of experience in industry and academia, Catia’s previous roles include positions at Wellmera, Novartis Global, and the Novartis Institute for Biomedical Research. Catia holds a Ph.D. in Neuroscience from the Weill Cornell Medical College, New York, and the University of Lisbon. 

Carsten Schwenke – HTA Expert

Carsten Schwenke is a licensed biostatistician and health economist, with a Ph.D. in public health, that has 25 years of experience in the pharmaceutical sector, focusing on clinical development and market access. He has been self-employed for the past 15 years, with a primary focus on the German HTA process. 

Meet our host:

Kenny Carberry – Director, Clinical Development, Alira Health 

Kenny leads business development efforts and initiatives for early-stage healthcare companies. His background covers various indications across pharma, medical devices, and digital health. In addition to his expertise in business development, Kenny has several years of experience in clinical trial operations and management. He offers a unique perspective on the clinical development lifecycle, from generating a comprehensive strategy to executing a successful trial. 


Related news

News September 27, 2022
AseBio and Alira Health Partner to Foster Market Access for Biotech Startups
Alira Health and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.
Biotech Market Access Startups
Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
News September 6, 2022
Alira Health Expands North American Capabilities with the Acquisition of Artisan Healthcare Consulting
The acquisition of Artisan strengthens and extends Alira Health’s Market Access and Management Consulting advisory practices in North America and globally.
Biotech Market Access Pharma Therapeutics
News September 5, 2022
Alira Health and Legit.Health Partner to Empower Patients in Dermatology Clinical Research
Alira Health digital health solutions combined with Legit.Health’s AI-driven image assessment tool offer a unique platform for dermatology DCT, RWE and DTx.
Decentralized Clinical Trials Dermatology DTx RWE
Publications September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
News August 17, 2022
Alira Health Joins the IRB Barcelona to Advance the Development of Personalized Cancer Treatments
We are pleased to announce we are joining the Institute for Research in Biomedicine (IRB Barcelona) as part of the CGI-Clinics project.
Patient Centric Real-World Evidence RWE
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.